Fibrocell Science Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
200.00
180.00
492.00
355.00
-
392
Cost of Goods Sold (COGS) incl. D&A
8,052.00
2,895.00
1,273.00
928.00
384.00
392
Gross Income
7,852.00
2,715.00
781.00
573.00
384.00
392
SG&A Expense
22,651.00
27,239.00
36,626.00
21,666.00
18,597.00
11,997
EBIT
30,503.00
29,954.00
37,407.00
22,239.00
18,981.00
12,389
Unusual Expense
1,053.00
3,930.00
-
7,182.00
3,513.00
2,583
Non Operating Income/Expense
-
368.00
2,946.00
7.00
56.00
300
Interest Expense
-
-
-
228.00
828.00
771
Pretax Income
31,554.00
25,650.00
34,453.00
15,292.00
16,240.00
10,277
Consolidated Net Income
31,554.00
25,650.00
34,453.00
15,292.00
16,240.00
10,277
Net Income
31,554.00
25,650.00
34,453.00
15,292.00
16,240.00
10,277
Net Income After Extraordinaries
31,554.00
25,650.00
34,453.00
15,292.00
16,240.00
10,277
Net Income Available to Common
31,554.00
25,650.00
34,453.00
15,292.00
20,603.00
11,126
EPS (Basic)
16.80
10.50
12.75
5.85
6.65
1.45
Basic Shares Outstanding
1,988.70
2,719.30
2,811.90
2,928.30
3,090.80
7,693.20
EPS (Diluted)
16.80
10.43
12.74
5.89
6.67
1.45
Diluted Shares Outstanding
2,013.10
2,731.30
2,823.40
2,929.50
3,092.00
7,693.20
EBITDA
29,640.00
29,071.00
36,640.00
21,675.00
18,597.00
11,997
Non-Operating Interest Income
2.00
6.00
8.00
-
-
-
Preferred Dividends
-
-
-
-
4,363.00
849
About Fibrocell Science
View Profile
